We are live on !
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter Est. Return
-0.52%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$82.9B
AUM Growth
-$1.95B
(-2.3%)
Cap. Flow
-$950M
Cap. Flow % of AUM
Cap. Flow %
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
800
New
57
Increased
242
Reduced
371
Closed
71
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$704M |
| 2 |
Howmet Aerospace
HWM
|
+$410M |
| 3 |
Nutrien
NTR
|
+$410M |
| 4 |
American Express
AXP
|
+$381M |
| 5 |
Stellantis
STLA
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$674M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$367M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$365M |
| 4 |
Sanofi
SNY
|
+$364M |
| 5 |
SHPG
Shire pic
SHPG
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.69% |
| 2 | Technology | 15.63% |
| 3 | Industrials | 12.68% |
| 4 | Healthcare | 11.72% |
| 5 | Energy | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Acco Brands
ACCO
$417M
| $38.6M | 0.05% |
3,073,479
-15,375
| -0.5% | -$193K |
2017 Q2
3 quarters
|
|
277
FerroAtlántica
GSM
$753M
| $37.8M | 0.05% |
3,523,167
-703,164
| -17% | -$10.7M |
2013 Q2
19 quarters
|
|
278
CDW
CDW
$18.8B
| $35.9M | 0.04% |
511,067
-143,559
| -22% | -$10.5M |
2013 Q3
18 quarters
|
|
279
Citizens Financial Group
CFG
$26.7B
| $35.8M | 0.04% |
853,817
-29,921
| -3% | -$1.34M |
2015 Q3
10 quarters
|
|
280
First Citizens BancShares
FCNCA
$24B
| $35.5M | 0.04% |
85,859
-3,218
| -4% | -$1.39M |
2013 Q2
19 quarters
|
|
|
CBM
281
DELISTED
Cambrex Corporation
CBM
| $35.5M | 0.04% |
677,887
-31,899
| -4% | -$1.71M |
2017 Q3
2 quarters
|
|
|
SYKE
282
DELISTED
SYKES Enterprises Inc
SYKE
| $34.7M | 0.04% |
1,199,136
-218,642
| -15% | -$6.63M |
2013 Q2
19 quarters
|
|
283
Del Monte Corp
DMC
$1.4B
| $34M | 0.04% |
752,611
+272,054
| +57% | +$12.8M |
2017 Q4
1 quarter
|
|
284
O-I Glass
OI
$896M
| $34M | 0.04% |
1,570,331
+282,052
| +22% | +$6.25M |
2017 Q3
2 quarters
|
|
285
Cactus
WHD
$4.3B
| $33.3M | 0.04% |
+1,234,804
| New | +$31.1M |
2018 Q1
0 quarters
|
|
286
NCR Voyix
VYX
$1.05B
| $32.8M | 0.04% |
1,694,566
-68,810
| -4% | -$1.45M |
2017 Q4
1 quarter
|
|
287
Insight Enterprises
NSIT
$4.71B
| $32.7M | 0.04% |
935,933
+108,444
| +13% | +$3.92M |
2013 Q2
19 quarters
|
|
|
288
Apple
AAPL
$5.01T
| $32.5M | 0.04% |
774,732
-15,647,544
| -95% | -$674M |
2013 Q2
19 quarters
|
|
289
La-Z-Boy
LZB
$1.2B
| $32.2M | 0.04% |
1,074,583
-102,027
| -9% | -$3.13M |
2017 Q2
3 quarters
|
|
290
FTI Consulting
FCN
$4.1B
| $31.4M | 0.04% |
648,641
-27,294
| -4% | -$1.23M |
2013 Q2
19 quarters
|
|
291
KT
KT
$8.74B
| $31.3M | 0.04% |
2,281,588
+1,109,134
| +95% | +$15.8M |
2017 Q1
4 quarters
|
|
292
Philip Morris
PM
$320B
| $30.7M | 0.04% |
+308,706
| New | +$32.2M |
2018 Q1
0 quarters
|
|
|
ESRX
293
DELISTED
Express Scripts Holding Company
ESRX
| $30.6M | 0.04% |
442,691
+47,626
| +12% | +$3.63M |
2013 Q2
19 quarters
|
|
294
DELISTED
Newfield Exploration
NFX
| $30.1M | 0.04% |
1,234,548
-3,757,717
| -75% | -$105M |
2016 Q2
7 quarters
|
|
295
Innovex International
INVX
$1.96B
| $30M | 0.04% |
669,163
+52,138
| +8% | +$2.55M |
2015 Q4
9 quarters
|
|
296
Hanmi Financial
HAFC
$923M
| $29.3M | 0.04% |
952,136
+199,046
| +26% | +$6.22M |
2016 Q3
6 quarters
|
|
|
AEGN
297
DELISTED
Aegion Corp
AEGN
| $28.6M | 0.03% |
1,249,035
-30,767
| -2% | -$743K |
2013 Q2
19 quarters
|
|
298
Ares Commercial Real Estate
ACRE
$191M
| $28.2M | 0.03% |
2,284,684
-106,778
| -4% | -$1.34M |
2013 Q2
19 quarters
|
|
299
WaFd
WAFD
$2.16B
| $28M | 0.03% |
810,284
+4,311
| +0.5% | +$153K |
2013 Q2
19 quarters
|
|
300
First Merchants
FRME
$2.49B
| $27.9M | 0.03% |
669,694
+132,704
| +25% | +$5.68M |
2017 Q3
2 quarters
|
|
Similar funds
Boston Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Boston Partners held 800 positions worth $82.9B, down 2.3% from $84.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners's Q1 2018 filing shows 57 new, 242 increased, 371 reduced and 71 closed positions. Its largest new stake was Nutrien: 8,190,940 shares worth $387M. The largest sale was Apple, an estimated $674M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2018 buy was Nutrien: 8,190,940 shares worth $387M.
- Boston Partners added most to Johnson & Johnson in Q1 2018, an estimated $704M increase.
- Boston Partners's biggest Q1 2018 reduction was Apple, cutting an estimated $674M.
- Boston Partners fully exited Sanofi in Q1 2018, selling an estimated $364M.
- Boston Partners's ten largest holdings make up 18% of its $82.9B portfolio in Q1 2018.
- Boston Partners opened 57 new positions and closed 71 in Q1 2018.
- Boston Partners's portfolio value fell 2.3% quarter-over-quarter to $82.9B.
Based on Boston Partners's 13F filing for Q1 2018, filed 4 May 2018.